Published in Nucleic Acids Res on February 25, 1990
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol (1990) 1.68
Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol (1992) 1.59
The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. EMBO J (1996) 1.33
Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol (1993) 1.31
A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J Virol (1990) 1.28
Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J Virol (1991) 1.27
YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol (1996) 1.24
Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology (2006) 1.16
Genomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs). Virology (2009) 1.08
Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner. Nucleic Acids Res (1994) 1.06
Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J Virol (2005) 1.06
Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription. J Biol Chem (2011) 1.02
Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol (2005) 1.01
The constitutively expressed octamer binding protein OTF-1 and a novel octamer binding protein expressed specifically in cervical cells bind to an octamer-related sequence in the human papillomavirus 16 enhancer. Nucleic Acids Res (1991) 0.97
The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res (1993) 0.96
NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression. J Virol (2004) 0.94
Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers. Cancer Prev Res (Phila) (2011) 0.93
Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106. J Gen Virol (2007) 0.92
NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region. J Virol (1993) 0.89
Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells. Biochem J (1999) 0.87
The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. J Virol (1995) 0.87
A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer. J Virol (1998) 0.87
Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation. J Virol (2006) 0.87
The HPV-activating cellular transcription factor Brn-3a is overexpressed in CIN3 cervical lesions. J Clin Invest (1998) 0.84
Loss of robustness and addiction to IGF1 during early keratinocyte transformation by human Papilloma virus 16. PLoS One (2007) 0.82
Biologic properties and nucleotide sequence analysis of human papillomavirus type 51. J Virol (1991) 0.82
Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells. PLoS One (2015) 0.81
Transactivation of the human papilloma virus 16 octamer motif by the octamer binding protein Oct-2 requires both the N and C terminal activation domains. Nucleic Acids Res (1993) 0.79
Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding. BMC Cancer (2006) 0.77
Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16. J Virol (2006) 0.77
Papillomavirus-Associated Tumor Formation Critically Depends on c-Fos Expression Induced by Viral Protein E2 and Bromodomain Protein Brd4. PLoS Pathog (2016) 0.76
Involvement of Brd4 in different steps of the papillomavirus life cycle. Virus Res (2016) 0.76
SOX2 as a New Regulator of HPV16 Transcription. Viruses (2017) 0.75
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
DNAse footprinting: a simple method for the detection of protein-DNA binding specificity. Nucleic Acids Res (1978) 30.43
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res (1987) 15.65
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (1987) 14.62
Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem (1987) 12.04
Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44
The primary structure and genetic organization of the bovine papillomavirus type 1 genome. Nature (1982) 7.24
Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature (1987) 6.76
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol (1987) 6.65
The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell (1988) 6.28
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene (1987) 4.02
Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J (1988) 3.81
Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci U S A (1988) 3.73
Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J (1988) 3.61
Many transcription factors interact synergistically with steroid receptors. Science (1988) 3.49
Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J Virol (1987) 3.24
A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci U S A (1987) 3.07
Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol (1989) 3.02
Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev (1989) 2.82
Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature (1985) 2.67
Genomic structure of the cottontail rabbit (Shope) papillomavirus. Proc Natl Acad Sci U S A (1985) 2.40
Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol (1986) 2.20
Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes Dev (1988) 1.92
Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol (1989) 1.83
Identification of a transforming gene of human papillomavirus type 16. J Virol (1989) 1.75
Characterization of a cell type-specific enhancer found in the human papilloma virus type 18 genome. EMBO J (1987) 1.67
Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types. Proc Natl Acad Sci U S A (1988) 1.66
Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis. J Virol (1986) 1.65
Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res (1989) 1.50
The oncogene jun and nuclear signalling. Trends Biochem Sci (1989) 1.26
Interaction of cellular factors related to the Jun oncoprotein with the promoter of a replication-dependent hamster histone H3.2 gene. Proc Natl Acad Sci U S A (1989) 1.18
Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and a phorbol ester. J Virol (1989) 1.04
Transcriptional regulatory elements in the noncoding region of human papillomavirus type 6. J Virol (1988) 0.99
Human papillomavirus-16 and genital cancer: are tests for the viral gene expression in vitro indicators for risk factors in vivo? Ann Acad Med Singapore (1988) 0.80
Epidermal growth factor induction of cellular proliferation and protooncogene expression in growth-arrested rat H4IIE hepatoma cells: role of cyclic adenosine monophosphate. Mol Endocrinol (1989) 0.79
Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp Cell Res (1985) 4.42
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1982) 3.49
Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol (1995) 3.26
Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med (1996) 3.16
A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci U S A (1987) 3.07
Construction of plasmid cloning vehicles that promote gene expression from the bacteriophage lambda pL promoter. Gene (1979) 3.00
Use of the lambda phage promoter PL to promote gene expression in hybrid plasmid cloning vehicles. Methods Enzymol (1979) 2.74
Purification of the TET repressor and TET operator from the transposon Tn10 and characterization of their interaction. J Biol Chem (1982) 2.10
The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol (1994) 2.01
New cosmid vectors developed for eukaryotic DNA cloning. Gene (1984) 1.97
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol (1999) 1.94
Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J Virol (1992) 1.88
Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol (1989) 1.83
Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res (1990) 1.81
Heterologous repressor-operator recognition among four classes of tetracycline resistance determinants. J Bacteriol (1985) 1.76
During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res (1992) 1.69
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol (1990) 1.68
Construction of an E. coli strain overproducing the Tn10-encoded TET repressor and its use for large scale purification. EMBO J (1984) 1.64
Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. J Natl Cancer Inst (1999) 1.62
Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol (1991) 1.57
Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res (1989) 1.50
Nucleotide sequence of the repressor gene of the RA1 tetracycline resistance determinant: structural and functional comparison with three related Tet repressor genes. Nucleic Acids Res (1984) 1.35
A bovine papilloma virus vector with a dominant resistance marker replicates extrachromosomally in mouse and E. coli cells. EMBO J (1983) 1.33
Expression, purification and operator binding of the transposon Tn1721-encoded Tet repressor. J Mol Biol (1986) 1.32
The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol (1999) 1.32
Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol (1993) 1.31
High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology (1996) 1.27
YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol (1996) 1.24
Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology (1995) 1.24
Expression of the human papillomavirus type 18 E7 gene by a cassette-vector system for the transcription and translation of open reading frames in eukaryotic cells. EMBO J (1987) 1.17
Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J Virol (2000) 1.17
Germ cell specification and regeneration in planarians. Cold Spring Harb Symp Quant Biol (2008) 1.17
Genomic diversity and evolution of papillomaviruses in rhesus monkeys. J Virol (1997) 1.16
The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J Virol (2000) 1.15
Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections. Int J Cancer (1995) 1.14
Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300. J Virol (1999) 1.11
Molecular diagnosis of genital HPV DNA types by polymerase chain reaction and sensitivity-standardized filter in situ hybridization in randomly sampled cohorts of Singapore women. Mol Cell Probes (1990) 1.11
Glucocorticoid- and progesterone-specific effects are determined by differential expression of the respective hormone receptors. Nature (1989) 1.09
Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner. Nucleic Acids Res (1994) 1.06
NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing. J Biol Chem (1997) 1.02
Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis (1993) 1.02
Genital papillomaviruses (PVs) and epidermodysplasia verruciformis PVs occur in the same monkey species: implications for PV evolution. Virology (1997) 1.00
Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Int J Cancer (1996) 0.97
Methylation sensitivity of the enhancer from the human papillomavirus type 16. J Biol Chem (1994) 0.95
Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses. J Virol (1998) 0.94
Long-term follow-up study of outcomes of bladder management in spinal cord injury patients under the care of the Midlands Centre for Spinal Injuries in Oswestry. Spinal Cord (2011) 0.94
Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts. Virology (1997) 0.94
Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides. Bioorg Med Chem (2000) 0.92
[Interdisciplinary AWMF guideline for the diagnostics of primary immunodeficiency]. Klin Padiatr (2011) 0.91
The Mastomys natalensis papillomavirus: nucleotide sequence, genome organization, and phylogenetic relationship of a rodent papillomavirus involved in tumorigenesis of cutaneous epithelia. Virology (1994) 0.91
Diagnostic sensitivity of polymerase chain reaction and Southern blot hybridization for the detection of human papillomavirus DNA in biopsy specimens from cervical lesions. Am J Clin Pathol (1991) 0.90
Identification of genomic sequences of three novel human papillomavirus sequences in cervical smears of Amazonian Indians. J Infect Dis (1994) 0.89
Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J Gen Virol (1999) 0.88
Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J Gen Virol (2000) 0.88
A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer. J Virol (1998) 0.87
Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells. Biochem J (1999) 0.87
Suppression of the yeast mutation rft1-1 by human p53. J Biol Chem (1995) 0.85
Apoptotic cell debris and phosphatidylserine-containing lipid vesicles induce apolipoprotein J (clusterin) gene expression in vital fibroblasts. Exp Cell Res (2001) 0.83
Subclinical human papillomavirus infection of the male lower genital tract: colposcopy, histology and DNA analysis. Int J STD AIDS (1991) 0.83
Analysis of the human guanylin gene and the processing and cellular localization of the peptide. Proc Natl Acad Sci U S A (1995) 0.83
Physical state, expression and regulation of two glucocorticoid-controlled genes on bovine papilloma virus vectors. J Mol Biol (1986) 0.82
Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. J Gen Virol (1994) 0.82
Thermus aquaticus DNA polymerase-catalysed chain reaction for the detection of human papillomaviruses. J Virol Methods (1990) 0.82
Cooperative action of the glucocorticoid receptor and transcription factors. Cold Spring Harb Symp Quant Biol (1988) 0.81
Human papillomavirus-16 and genital cancer: are tests for the viral gene expression in vitro indicators for risk factors in vivo? Ann Acad Med Singapore (1988) 0.80
Human papillomavirus type 2c is identical to human papillomavirus type 27. Virology (1994) 0.79
Elucidating the population histories and transmission dynamics of papillomaviruses using phylogenetic trees. J Mol Evol (1997) 0.79
Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. J Gen Virol (1995) 0.78
Multiple signal transduction pathways regulate clusterin (gp 80) gene expression in MDCK cells. J Mol Endocrinol (1996) 0.77
Constitutive and steroid hormone regulated transcriptional enhancer elements in the genome of the human papilloma virus type 16, which is associated with neoplasia of the cervix. Cancer Detect Prev (1988) 0.76
Analysis of tet operator-TET repressor complexes by thermal denaturation studies. Nucleic Acids Res (1982) 0.75
Inhaled corticosteroids and bone density. Lancet (2000) 0.75
Nucleic acid hybridization and the polymerase chain reaction in biology and medicine, with special reference to the detection of human papillomaviruses. Ann Acad Med Singapore (1989) 0.75
Genital human papillomavirus infection among women from major ethnic groups in Singapore. Asia Oceania J Obstet Gynaecol (1990) 0.75
No association between human herpesvirus 8 and arsenical skin cancers. Int J Dermatol (2001) 0.75
Cross talk in photochemical three-dimensional optical recording. Opt Lett (2004) 0.75
[Preventive orthodontics for crossbite cases in primary dentition (author's transl)]. Shigaku (1974) 0.75
Patterns and implications of subclinical vulval human papillomavirus infection: the impact of PCR analysis. Asia Oceania J Obstet Gynaecol (1992) 0.75
Viruses and cancer, with particular focus on human papillomaviruses in neoplastic lesions of the cervix uteri. Ann Acad Med Singapore (1990) 0.75
Visual acuity, lens flexure, and residual astigmatism of keratoconic eyes as a function of back optic zone radius of rigid lenses. Cont Lens Anterior Eye (2000) 0.75